Top Value Stocks To Follow Now – December 19th

Invesco QQQ, CoreWeave, Rocket Lab, Amicus Therapeutics, ProShares UltraPro Short QQQ, Rivian Automotive, and Uber Technologies are the seven Value stocks to watch today, according to MarketBeat’s stock screener tool. Value stocks are shares of companies that appear to trade at prices below their fundamental worth, as indicated by metrics like low price-to-earnings or price-to-book ratios and often higher dividend yields. Investors buy value stocks expecting the market will eventually recognize the company’s true value, producing capital gains and income, and they tend to come from more mature, stable businesses with slower growth. These companies had the highest dollar trading volume of any Value stocks within the last several days.

Invesco QQQ (QQQ)

PowerShares QQQ Trust, Series 1 is a unit investment trust that issues securities called Nasdaq-100 Index Tracking Stock. The Trust’s investment objective is to provide investment results that generally correspond to the price and yield performance of the Nasdaq-100 Index. The Trust provides investors with the opportunity to purchase units of beneficial interest in the Trust representing proportionate undivided interests in the portfolio of securities held by the Trust, which consists of substantially all of the securities, in substantially the same weighting, as the component securities of the Nasdaq-100 Index.

Read Our Latest Research Report on QQQ

CoreWeave (CRWV)

Read Our Latest Research Report on CRWV

Rocket Lab (RKLB)

Rocket Lab USA, Inc., a space company, provides launch services and space systems solutions for the space and defense industries. The company provides launch services, spacecraft design services, spacecraft components, spacecraft manufacturing, and other spacecraft and on-orbit management solutions; and constellation management services, as well as designs and manufactures small and medium-class rockets.

Read Our Latest Research Report on RKLB

Amicus Therapeutics (FOLD)

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant; and Pombiliti + Opfolda, for the treatment of late onset.

Read Our Latest Research Report on FOLD

ProShares UltraPro Short QQQ (SQQQ)

ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.

Read Our Latest Research Report on SQQQ

Rivian Automotive (RIVN)

Rivian Automotive, Inc., together with its subsidiaries, designs, develops, manufactures, and sells electric vehicles and accessories. The company offers consumer vehicles, including a two-row, five-passenger pickup truck under the R1T brand, a three-row, seven-passenger sport utility vehicle under the R1S name.

Read Our Latest Research Report on RIVN

Uber Technologies (UBER)

Uber Technologies, Inc. develops and operates proprietary technology applications in the United States, Canada, Latin America, Europe, the Middle East, Africa, and Asia excluding China and Southeast Asia. It operates through three segments: Mobility, Delivery, and Freight. The Mobility segment connects consumers with a range of transportation modalities, such as ridesharing, carsharing, micromobility, rentals, public transit, taxis, and other modalities; and offers riders in a variety of vehicle types, as well as financial partnerships products and advertising services.

Read Our Latest Research Report on UBER

Recommended Stories